ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 91 filers reported holding ADMA BIOLOGICS INC in Q4 2021. The put-call ratio across all filers is 4.64 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $59 | +59.5% | 16,360 | +61.8% | 0.00% | – |
| Q2 2023 | $37 | +12.1% | 10,110 | 0.0% | 0.00% | – |
| Q1 2023 | $33 | -28.3% | 10,110 | -15.1% | 0.00% | – |
| Q4 2022 | $46 | -99.8% | 11,902 | +17.7% | 0.00% | – |
| Q3 2022 | $24,000 | -48.9% | 10,110 | -61.1% | 0.00% | – |
| Q1 2022 | $47,000 | +46.9% | 26,010 | +13.0% | 0.00% | – |
| Q4 2021 | $32,000 | +14.3% | 23,010 | -8.0% | 0.00% | – |
| Q3 2021 | $28,000 | -41.7% | 25,010 | -16.7% | 0.00% | – |
| Q2 2021 | $48,000 | -45.5% | 30,010 | -40.4% | 0.00% | – |
| Q1 2021 | $88,000 | – | 50,354 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Velan Capital Investment Management LP | 4,000,000 | $15,520,000 | 13.71% |
| Stonepine Capital Management, LLC | 6,940,000 | $26,927,200 | 11.33% |
| Caligan Partners LP | 2,676,093 | $10,383,241 | 8.64% |
| Altium Capital Management LP | 2,870,000 | $11,135,600 | 5.66% |
| AWM Investment Company, Inc. | 6,015,000 | $23,338,200 | 3.36% |
| EAM Investors, LLC | 1,749,598 | $6,788,440 | 1.40% |
| Perceptive Advisors | 11,900,255 | $46,172,989 | 1.30% |
| EAM Global Investors LLC | 836,323 | $3,244,933 | 0.84% |
| Potomac Capital Management, Inc. | 120,000 | $466 | 0.54% |
| OBERWEIS ASSET MANAGEMENT INC/ | 536,900 | $2,083,172 | 0.44% |